We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

PTAB Says Rituxan Patent Challenged By Pfizer Is Obvious

Law360 (November 1, 2018, 7:03 PM EDT) -- The Patent Trial and Appeal Board on Wednesday handed a win to Pfizer Inc. in its challenge of a Biogen Inc. patent covering the cancer treatment Rituxan, with the board invalidating...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.